EW vs FOR · P/E 47, rev $1.39B vs P/E 8.7, rev $1.66B
Edwards Lifesciences Corp (EW) versus Forestar Group Inc (FOR) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Forestar Group Inc (FOR) is a real estate - development company listed on NYSE.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported FOR revenue for 2025-09-30 was $1.66B. Net income was $167.9M. Revenue was up 10.1% from 2024-09-30 to 2025-09-30. FOR currently screens at market cap $1.45B and trailing P/E 8.7.
EW currently screens at market cap $49.91B and trailing P/E 46.9. FOR currently screens at market cap $1.45B and trailing P/E 8.7.
Not investment advice. Open the EW and FOR stock pages for the full models.
Not investment advice.